Search for: "Roche Holdings Incorporated" Results 1 - 20 of 39
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Oct 2023, 9:25 am by Keith Szeliga and Daniel Alvarado
The Cost Principles also apply to the determination, negotiation, and allowance of costs whenever required by a contract clause.[6] The FAR requires the Government to incorporate the FAR Cost Principles by reference in contracts with commercial organizations as the basis for: (1) determining reimbursable costs; (2) negotiating indirect cost rates; (3) proposing, negotiating, or determining costs under terminated contracts; (4) price revision of fixed-price incentive contracts; (5) price… [read post]
29 Jun 2023, 12:29 am by Roel van Woudenberg
The appellant requested that the decision of the opposition division not to admit document D18 into the proceedings be overturned.1.1 This request is subject to the Board's discretionary power to hold inadmissible facts, evidence and requests which could have been presented or were not admitted in the first instance proceedings (Article 12(4) RPBA 2007, which applies in view of Article 25(2) RPBA 2020). [read post]
1 Jul 2021, 8:48 am by Lisa Larrimore Ouellette
Roche Molecular Systems, Inc., 563 U.S. 776 (2011) (re-affirming assignment priority rules in cases of conflicting patent assignments).DissentOn the other hand, if the approach announced by the dissent takes hold, or is extended to other doctrinal areas, the resulting legal changes could be felt on a massive scale. [read post]
9 Mar 2021, 3:50 am by MaxVal
The figure below illustrates the sensing system incorporating the alcohol sensor. [read post]
26 Feb 2021, 3:52 am by MaxVal
In this week’s featured patent applications, we cover the latest from Cargill, Boston Scientific, Roche, Abbott, Medtronic, Merck, Mastercard, Intel, Apple, Microsoft and IBM. [read post]
17 Jan 2021, 6:15 pm by Omar Ha-Redeye
The Court in Crookes reinterpreted the notion of publication online, finding that a deliberate act can include the failure to remove defamatory content once actual or constructive knowledge exists, [59] A more nuanced approach to revising the publication rule, and one that can be applied effectively to new media, would be for the Court to hold that in Canadian law, a reference to defamatory content can satisfy the requirements of the first component of publication if it makes the… [read post]
25 Jan 2016, 2:01 pm
Hahah nadia think about it like I said 6pm to give a better response.Patel: Do you hold back from anything when you talk to me or the way you act with me NO, why do you EXPECT ME TO DO THE SAME NADIA? [read post]
11 Feb 2015, 12:23 pm
Bayer’s predecessor, Hoffmann-La Roche, filed a US application for FLANAX in February 2004. [read post]
9 Jan 2015, 9:45 am
The court goes on to apply the good-faith exception, however, because the court’s holding is somewhat novel under the circumstances. [read post]
7 Nov 2014, 5:52 am
We’ve made no secret of our distaste for the so called “heeding presumption” – that juries may presume that any alternative “adequate” warning would have been heeded by the plaintiff (or, in prescription medical product cases, the prescriber). [read post]
27 Feb 2014, 9:38 am by Dennis Crouch
Cir. 2011) and In re Zimmer Holdings, Inc., 609 F.3d 1378, 1381 (Fed. [read post]
7 Oct 2013, 11:06 am by Lawrence B. Ebert
Hoffman-LA Roche Ltd., 580 F.3d 1340, 1362 (Fed. [read post]
17 Dec 2011, 9:05 am by Andrew Frisch
The holdings of both the American Express cases and Ragone were based, in contrast and as this decision must be, on federal arbitral law, and AT & T in no way alters the relevance of those binding circuit holdings. [read post]
19 Oct 2011, 11:27 am by Dennis Crouch
" But the Supreme Court should affirm the Federal Circuit's holding on subject matter eligibility. [read post]
26 Jul 2011, 5:26 am by Stefanie Levine
  Roche commercialized a product incorporating the technology covered by the Stanford patents and Stanford asserted its patents against Roche. [read post]
26 Jul 2011, 5:26 am by Stefanie Levine
  Roche commercialized a product incorporating the technology covered by the Stanford patents and Stanford asserted its patents against Roche. [read post]